T Cells Modified with CD70 as an Alternative Cellular Vaccine for Antitumor Immunity
Cancer Research and Treatment. 2020;52(3):747-763 
Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunity
Vaccine. 2010;28(6):1468-1476
Adoptive Cellular Therapy With Synthetic T Cells as an “Instant Vaccine” for Cancer and Immunity
The Vaccine Book. 2016;581-596
Augmentation of antitumor immunity by genetically engineered fibroblast cells to express both B7.1 and interleukin-7
Vaccine. 2000;18(25):2886-2894
Engineered Fusion Hybrid Vaccine of IL-18 Gene-Modified Tumor Cells and Dendritic Cells Induces Enhanced Antitumor Immunity
Cancer Biotherapy and Radiopharmaceuticals. 2004;19(3):322-330
721. Enhanced Antitumor Cellular Immunity Induced by a Novel HPV-16 DNA Vaccine Encoding a E6/E7 Fusion Consensus Protein
Molecular Therapy. 2008;16:S269
Gene-modified tumor cells as cellular vaccine
Cancer Immunology, Immunotherapy. 1996;43(3):165-173
Comment on “Pneumococcal polysaccharide vaccination induces polysaccharide-specific B cells in adult peripheral blood expressing CD19+CD20+CD3−CD70−CD27+IgM+CD43+CD5+/−”
Vaccine. 2014;32(25):2940-2941
Identification of effector T cells responsible for enhanced antitumor immunity induced by tumor vaccine and pyran copolymer
Cancer Immunology Immunotherapy. 1982;12(3):
432. A Novel Cancer Cell Vaccine Using Induced Pluripotent Stem Cells Genetically Engineered To Produce GM-CSF Elicits Substantial Antitumor Immunity in a Syngeneic Mouse Model
Molecular Therapy. 2013;21:S166